| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| UNITED STATES | Region | 2025 | USD | 12,864.0 | 64.1% |
| Non-US | Region | 2025 | USD | 7,210.0 | 35.9% |
| UNITED STATES | Region | 2024 | USD | 10,210.0 | 61.0% |
| Non-US | Region | 2024 | USD | 6,538.0 | 39.0% |
| UNITED STATES | Region | 2023 | USD | 8,425.0 | 59.2% |
| Non-US | Region | 2023 | USD | 5,816.0 | 40.8% |
| UNITED STATES | Region | 2022 | USD | 7,632.0 | 59.9% |
| Non-US | Region | 2022 | USD | 5,111.0 | 40.1% |
| UNITED STATES | Region | 2021 | USD | 6,911.0 | 58.1% |
| Non-US | Region | 2021 | USD | 4,978.0 | 41.9% |
| UNITED STATES | Region | 2020 | USD | 5,701.0 | 57.5% |
| Non-US | Region | 2020 | USD | 4,212.0 | 42.5% |
| Cardiovascular | Product | 2025 | USD | 13,266.0 | 66.0% |
| MedSurg | Product | 2025 | USD | 6,829.0 | 34.0% |
| Cardiovascular | Product | 2024 | USD | 10,755.0 | 64.2% |
| MedSurg | Product | 2024 | USD | 5,993.0 | 35.8% |
| Cardiovascular | Product | 2023 | USD | 8,819.0 | 61.9% |
| MedSurg | Product | 2023 | USD | 5,422.0 | 38.1% |
| Cardiovascular | Product | 2022 | USD | 8,161.0 | 61.7% |
| MedSurg | Product | 2022 | USD | 5,057.0 | 38.3% |
| Cardiovascular | Product | 2021 | USD | 4,858.0 | 40.9% |
| MedSurg | Product | 2021 | USD | 3,724.0 | 31.4% |
| Cardiac Rhythm Management | Product | 2021 | USD | 3,293.0 | 27.7% |
| Cardiovascular | Product | 2020 | USD | 3,876.0 | 55.8% |
| MedSurg | Product | 2020 | USD | 3,066.0 | 44.2% |
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
